Osterloh Ian,Wicker Pierre,Braeckman Rene,Soni Paresh,Rowe Jonathan
申请号：
NZ71206811
公开号：
NZ712068A
申请日:
2011.11.28
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Disclosed is the use of ethyl eicosapentaenoate in the preparation of a medicament for treating hypertriglyceridemia in a subject identified as having a fasting baseline triglyceride level of about 500 mg/dl to about 2000 mg/dl and as being allergic to fish or seafood, wherein said medicament contains substantially no docosahexaenoic acid (DHA) or derivative thereof, and less than about 1%, by weight, of proteins, if any, and wherein the medicament does not cause skin rash or wherein the subject experiences reduced incidence of skin rash compared to placebo or to an equivalent milligram dose of a commercially available prescription omega-3 fatty acid composition.
